Cigna Pathwell Specialty℠ Drug List
Cigna Pathwell Specialty℠ is for patients using a specialty medication to treat a complex medical condition. As part of this program, certain medications must be administered by a provider in the Cigna Pathwell Specialty Network or ordered from an in-network specialty pharmacy to be covered.
About this drug list
This is a list of infused and injected specialty medications that must be administered by a provider in the Cigna Pathwell Specialty Network, or ordered from an in-network specialty pharmacy, for them to be covered. Medications are listed alphabetically by condition with generic medications listed in all lowercase letters and brand-name medications in all capital letters. Additionally, this list contains drugs that may be on a 180 Day Hold and/or the Drug Removal Table list. This drug list is automatically updated so it provides the latest list of medications.
Go to Cigna.com/Pathwellspecialty for additional information or to find a facility in the Cigna Pathwell Specialty Network near you.
Drug Name/Generic Name | Brand Name/Trade Name | Purpose | HCPCS Code | Precert Required? | 180 DH | DRT Drug List |
---|---|---|---|---|---|---|
abatacept/maltose | ORENCIA | RA/PSORIASIS/CROHNS | J0129 | Yes | No | Yes |
ado-trastuzumab emtansine | KADCYLA | CANCER | J9354 | Yes | No | No |
aducanumab-avwa | ADUHELM | INJECTABLES - SPECIALTY OTHER | J0172 | Yes | No | No |
agalsidase beta | FABRAZYME | HEREDITARY METABOLIC DISORDERS | J0180 | Yes | No | No |
alemtuzumab | LEMTRADA | MULTIPLE SCLEROSIS | J0202 | Yes | No | Yes |
alglucosidase alfa | LUMIZYME | HEREDITARY METABOLIC DISORDERS | J0221 | Yes | No | No |
alpha-1-proteinase inhibitor | ARALAST NP | HEREDITARY METABOLIC DISORDERS | J0256 | Yes | No | No |
alpha-1-proteinase inhibitor | GLASSIA | HEREDITARY METABOLIC DISORDERS | J0257 | Yes | No | No |
alpha-1-proteinase inhibitor | PROLASTIN C | HEREDITARY METABOLIC DISORDERS | J0256 | Yes | No | No |
alpha-1-proteinase inhibitor | ZEMAIRA | HEREDITARY METABOLIC DISORDERS | J0256 | Yes | No | No |
amivantamab-vmjw | RYBREVANT | CANCER | J9061 | Yes | No | No |
anifrolumab-fnia | SAPHNELO | INJECTABLES - SPECIALTY OTHER | J0491 | Yes | No | Yes |
antihem.fviii,sin-chn,b-dm tru | AFSTYLA | HEMOPHILIA | J7210 | Yes | No | No |
antihemo.fviii,full length peg | ADYNOVATE | HEMOPHILIA | J7207 | Yes | No | No |
antihemoph.fviii,b-domain del | XYNTHA | HEMOPHILIA | J7185 | Yes | No | No |
antihemoph.fviii,b-domain del | XYNTHA SOLOFUSE | HEMOPHILIA | J7185 | Yes | No | No |
antihemoph.fviii,b-dom truncat | NOVOEIGHT | HEMOPHILIA | J7182 | Yes | No | No |
antihemoph.fviii,hek b-delete | NUWIQ | HEMOPHILIA | J7209 | Yes | No | No |
antihemoph.fviii rec,fc fusion | ELOCTATE | HEMOPHILIA | J7205 | Yes | No | No |
antihemophil.fviii,full length | ADVATE | HEMOPHILIA | J7192 | Yes | No | No |
antihemophil.fviii,full length | KOGENATE FS | HEMOPHILIA | J7192 | Yes | No | No |
antihemophil.fviii,full length | KOVALTRY | HEMOPHILIA | J7211 | Yes | No | No |
antihemophilic factor, human | HEMOFIL M | HEMOPHILIA | J7190 | Yes | No | No |
antihemophilic factor, human | KOATE | HEMOPHILIA | J7190 | Yes | No | No |
antihemophilic factor, hum rec | RECOMBINATE | HEMOPHILIA | J7192 | Yes | No | No |
antihemophilic factor/vwf | ALPHANATE | HEMOPHILIA | J7186 | Yes | No | No |
antihemophilic factor/vwf | HUMATE-P | HEMOPHILIA | J7187 | Yes | No | No |
antihemophilic factor/vwf | WILATE | HEMOPHILIA | J7183 | Yes | No | No |
antihemophilic fviii,rec porc | OBIZUR | HEMOPHILIA | J7188 | Yes | No | No |
anti-inhibitor coagulant comp. | FEIBA | HEMOPHILIA | J7198 | Yes | No | No |
antithrombin iii (plasma der) | THROMBATE III | OTHER BLOOD DISORDERS | J7197 | Yes | No | No |
atezolizumab | TECENTRIQ | CANCER | J9022 | Yes | No | No |
atezolizumab-hyaluronidas-tqjs | TECENTRIQ HYBREZA | CANCER | J9024 | Yes | No | No |
atezolizumab-hyaluronidas-tqjs | TECENTRIQ HYBREZA | CANCER | J9999 | Yes | No | No |
avalglucosidase alfa-ngpt | NEXVIAZYME | HEREDITARY METABOLIC DISORDERS | J0219 | Yes | No | No |
axatilimab-csfr | NIKTIMVO | INJECTABLES - SPECIALTY OTHER | J3590 | Yes | Yes | No |
axatilimab-csfr | NIKTIMVO | INJECTABLES - SPECIALTY OTHER | J9038 | Yes | Yes | No |
belatacept | NULOJIX | INJECTABLES - SPECIALTY OTHER | J0485 | Yes | No | No |
belimumab | BENLYSTA | AUTOIMMUNE/OTHER INFLAMMATORY | J0490 | Yes | No | No |
bendamustine hcl | BELRAPZO | CANCER | J9036 | Yes | No | No |
bendamustine hcl | BENDAMUSTINE HCL | CANCER | J9033 | Yes | No | No |
bendamustine hcl | BENDAMUSTINE HCL | CANCER | J9036 | Yes | No | No |
bendamustine hcl | BENDAMUSTINE HCL | CANCER | J9058 | Yes | No | No |
bendamustine hcl | BENDAMUSTINE HCL | CANCER | J9059 | Yes | No | No |
bendamustine hcl | BENDEKA | CANCER | J9034 | Yes | No | No |
bendamustine hcl | TREANDA | CANCER | J9033 | Yes | No | No |
bendamustine hcl | VIVIMUSTA | CANCER | J9056 | Yes | No | No |
benralizumab | FASENRA | ASTHMA/ALLERGY | J0517 | Yes | No | No |
bevacizumab | AVASTIN | CANCER | J9035 | Yes | No | Yes |
bevacizumab-adcd | VEGZELMA | CANCER | Q5129 | Yes | No | Yes |
bevacizumab-awwb | MVASI | CANCER | Q5107 | Yes | No | No |
bevacizumab-bvzr | ZIRABEV | CANCER | Q5118 | Yes | No | No |
bevacizumab-maly | ALYMSYS | CANCER | Q5126 | Yes | No | Yes |
blinatumomab | BLINCYTO | CANCER | J9039 | Yes | No | No |
brentuximab vedotin | ADCETRIS | CANCER | J9042 | Yes | No | No |
burosumab-twza | CRYSVITA | BONE | J0584 | Yes | No | No |
c1 esterase inhibitor | BERINERT | ASTHMA/ALLERGY | J0597 | Yes | No | Yes |
c1 esterase inhibitor | CINRYZE | ASTHMA/ALLERGY | J0598 | Yes | No | No |
c1 esterase inhibitor, recomb | RUCONEST | ASTHMA/ALLERGY | J0596 | Yes | No | Yes |
cabazitaxel | JEVTANA | CANCER | J9043 | Yes | No | No |
cabotegravir/rilpivirine | CABENUVA | INFECTIOUS DISEASE | J0741 | Yes | No | No |
canakinumab/pf | ILARIS | AUTOIMMUNE/OTHER INFLAMMATORY | J0638 | Yes | No | No |
caplacizumab-yhdp | CABLIVI | OTHER BLOOD DISORDERS | C9047 | Yes | No | No |
carfilzomib | KYPROLIS | CANCER | J9047 | Yes | No | No |
casimersen | AMONDYS-45 | GENETIC NEUROMUSCLAR DISORDERS | J1426 | Yes | No | No |
cemiplimab-rwlc | LIBTAYO | CANCER | J9119 | Yes | No | No |
cerliponase alfa | BRINEURA | HEREDITARY METABOLIC DISORDERS | J0567 | Yes | No | No |
certolizumab pegol | CIMZIA (2 PACK) | RA/PSORIASIS/CROHNS | J0717 | Yes | No | No |
cetuximab | ERBITUX | CANCER | J9055 | Yes | No | No |
cipaglucosidase alfa-atga | POMBILITI | HEREDITARY METABOLIC DISORDERS | J1203 | Yes | No | No |
coagulation factor viia,recomb | NOVOSEVEN RT | HEMOPHILIA | J7189 | Yes | No | No |
coagulation factor x | COAGADEX | HEMOPHILIA | J7175 | Yes | No | No |
coagulation viia,recomb-jncw | SEVENFACT | HEMOPHILIA | J7189 | Yes | No | No |
coagulation viia,recomb-jncw | SEVENFACT | HEMOPHILIA | J7212 | Yes | No | No |
crizanlizumab-tmca | ADAKVEO | OTHER BLOOD DISORDERS | J0791 | Yes | No | No |
crovalimab-akkz | PIASKY | OTHER BLOOD DISORDERS | J1307 | Yes | No | Yes |
daratumumab | DARZALEX | CANCER | J9145 | Yes | No | No |
daratumumab-hyaluronidase-fihj | DARZALEX FASPRO | CANCER | J9144 | Yes | No | No |
darbepoetin alfa in polysorbat | ARANESP | ANEMIA | J0881 | Yes | No | No |
datopotamab deruxtecan-dlnk | DATROWAY | CANCER | J9999 | Yes | Yes | No |
decitabine | DACOGEN | CANCER | J0894 | Yes | No | No |
decitabine | DECITABINE | CANCER | J0893 | Yes | No | No |
decitabine | DECITABINE | CANCER | J0894 | Yes | No | No |
denosumab | PROLIA | BONE | J0897 | Yes | No | No |
denosumab | XGEVA | BONE | J0897 | Yes | No | No |
dostarlimab-gxly | JEMPERLI | CANCER | J9272 | Yes | No | No |
doxorubicin hcl peg-liposomal | DOXIL | CANCER | Q2050 | Yes | No | No |
doxorubicin hcl peg-liposomal | DOXORUBICIN HCL LIPOSOME | CANCER | Q2050 | Yes | No | No |
durvalumab | IMFINZI | CANCER | J9173 | Yes | No | No |
ecallantide | KALBITOR | ASTHMA/ALLERGY | J1290 | Yes | No | Yes |
eculizumab | SOLIRIS | OTHER BLOOD DISORDERS | J1299 | Yes | No | No |
eculizumab | SOLIRIS | OTHER BLOOD DISORDERS | J1300 | Yes | No | No |
edaravone | EDARAVONE | GENETIC NEUROMUSCLAR DISORDERS | J1301 | Yes | No | No |
edaravone | RADICAVA | GENETIC NEUROMUSCLAR DISORDERS | J1301 | Yes | No | No |
efgartigimod alfa-fcab | VYVGART | INJECTABLES - SPECIALTY OTHER | J9332 | Yes | No | No |
efgartigimod-hyaluronidas-qvfc | VYVGART HYTRULO | INJECTABLES - SPECIALTY OTHER | J9334 | Yes | No | No |
eflapegrastim-xnst | ROLVEDON | NEUTROPENIA | J1449 | Yes | No | No |
elapegademase-lvlr | REVCOVI | INJECTABLES - SPECIALTY OTHER | J3590 | Yes | No | No |
elosulfase alfa | VIMIZIM | HEREDITARY METABOLIC DISORDERS | J1322 | Yes | No | No |
elotuzumab | EMPLICITI | CANCER | J9176 | Yes | No | No |
elranatamab-bcmm | ELREXFIO | CANCER | J1323 | Yes | No | No |
emapalumab-lzsg | GAMIFANT | OTHER BLOOD DISORDERS | J9210 | Yes | No | No |
enfortumab vedotin-ejfv | PADCEV | CANCER | J9177 | Yes | No | No |
epcoritamab-bysp | EPKINLY | CANCER | J9321 | Yes | No | No |
epoetin alfa | EPOGEN | ANEMIA | J0885 | Yes | No | No |
epoetin alfa | PROCRIT | ANEMIA | J0885 | Yes | No | No |
epoetin alfa-epbx | RETACRIT | ANEMIA | Q5106 | Yes | No | No |
eptinezumab-jjmr | VYEPTI | INJECTABLES - SPECIALTY OTHER | J3032 | Yes | No | Yes |
eribulin mesylate | ERIBULIN MESYLATE | CANCER | J9179 | Yes | No | No |
eribulin mesylate | HALAVEN | CANCER | J9179 | Yes | No | No |
eteplirsen | EXONDYS-51 | GENETIC NEUROMUSCLAR DISORDERS | J1428 | Yes | No | No |
evinacumab-dgnb | EVKEEZA | INJECTABLES - SPECIALTY OTHER | J1305 | Yes | No | No |
factor ix | ALPHANINE SD | HEMOPHILIA | J7193 | Yes | No | No |
factor ix cplx(pcc)no4,3factor | PROFILNINE | HEMOPHILIA | J7194 | Yes | No | No |
factor ix human recombinant | BENEFIX | HEMOPHILIA | J7195 | Yes | No | No |
factor ix human recombinant | RIXUBIS | HEMOPHILIA | J7200 | Yes | No | No |
factor ix human recomb,thr 148 | IXINITY | HEMOPHILIA | J7195 | Yes | No | No |
factor ix human recomb,thr 148 | IXINITY | HEMOPHILIA | J7213 | No | No | No |
factor ix human rec,pegylated | REBINYN | HEMOPHILIA | J7203 | Yes | No | No |
factor ix rec, fc fusion protn | ALPROLIX | HEMOPHILIA | J7201 | Yes | No | No |
factor ix recom,albumin fusion | IDELVION | HEMOPHILIA | J7202 | Yes | No | No |
factor xiii | CORIFACT | HEMOPHILIA | J7180 | Yes | No | No |
factor xiii a-subunit,recomb | TRETTEN | HEMOPHILIA | J7181 | Yes | No | No |
fam-trastuzumab deruxtecn-nxki | ENHERTU | CANCER | J9358 | Yes | No | No |
fibrinogen | RIASTAP | OTHER BLOOD DISORDERS | J7178 | Yes | No | No |
fosdenopterin hydrobromide | NULIBRY | HEREDITARY METABOLIC DISORDERS | J3490 | Yes | No | No |
fulvestrant | FASLODEX | CANCER | J9395 | Yes | No | No |
fulvestrant | FULVESTRANT | CANCER | J9393 | Yes | No | No |
fulvestrant | FULVESTRANT | CANCER | J9394 | Yes | No | No |
fulvestrant | FULVESTRANT | CANCER | J9395 | Yes | No | No |
fviii rec,b-dom delet peg-aucl | JIVI | HEMOPHILIA | J7208 | Yes | No | No |
fviii rec,b-dom trunc peg-exei | ESPEROCT | HEMOPHILIA | J7204 | Yes | No | No |
fviii rec,fc-vwf-xten,bdd-ehtl | ALTUVIIIO | HEMOPHILIA | J7214 | Yes | No | No |
galsulfase | NAGLAZYME | HEREDITARY METABOLIC DISORDERS | J1458 | Yes | No | No |
givosiran sodium | GIVLAARI | HEREDITARY METABOLIC DISORDERS | J0223 | Yes | No | No |
glofitamab-gxbm | COLUMVI | CANCER | J9286 | Yes | No | No |
golimumab | SIMPONI ARIA | RA/PSORIASIS/CROHNS | J1602 | Yes | No | No |
golodirsen | VYONDYS-53 | GENETIC NEUROMUSCLAR DISORDERS | J1429 | Yes | No | No |
goserelin acetate | ZOLADEX | CANCER | J9202 | Yes | No | No |
guselkumab | TREMFYA | RA/PSORIASIS/CROHNS | J1628 | Yes | No | No |
ibalizumab-uiyk | TROGARZO | INJECTABLES - SPECIALTY OTHER | J1746 | Yes | No | No |
idursulfase | ELAPRASE | HEREDITARY METABOLIC DISORDERS | J1743 | Yes | No | No |
igg/hyaluronidase,recombinant | HYQVIA | IVIG/IMMUNE RELATED | J1575 | Yes | No | Yes |
imetelstat sodium | RYTELO | CANCER | J0870 | Yes | No | Yes |
imiglucerase | CEREZYME | HEREDITARY METABOLIC DISORDERS | J1786 | Yes | No | No |
imm glob g (igg)/sorb/iga 0-50 | FLEBOGAMMA DIF | IVIG/IMMUNE RELATED | J1572 | Yes | No | No |
immune globul g/gly/iga avg 46 | GAMMAKED | IVIG/IMMUNE RELATED | J1561 | Yes | No | No |
immune globul g/gly/iga avg 46 | GAMUNEX-C | IVIG/IMMUNE RELATED | J1561 | Yes | No | No |
immune globul g (igg)/glycine | GAMASTAN | IVIG/IMMUNE RELATED | 90281 | Yes | No | No |
immune globul g (igg)/glycine | GAMASTAN S-D | IVIG/IMMUNE RELATED | 90281 | Yes | No | No |
immune globulin,gamma(igg)klhw | XEMBIFY | IVIG/IMMUNE RELATED | J1558 | Yes | No | No |
immune globulin,gamma(igg)slra | ASCENIV | IVIG/IMMUNE RELATED | J1554 | Yes | No | Yes |
immune globulin,gamma(igg)stwk | ALYGLO | IVIG/IMMUNE RELATED | J1552 | Yes | No | Yes |
immun glob g/gly/gluc/iga 0-50 | GAMMAGARD S-D | IVIG/IMMUNE RELATED | J1566 | Yes | No | Yes |
immun glob g(igg)/gly/iga 0-50 | GAMMAPLEX | IVIG/IMMUNE RELATED | J1557 | Yes | No | No |
immun glob g(igg)/gly/iga ov50 | BIVIGAM | IVIG/IMMUNE RELATED | J1556 | Yes | No | No |
immun glob g(igg)/gly/iga ov50 | CUVITRU | IVIG/IMMUNE RELATED | J1555 | Yes | No | No |
immun glob g(igg)/gly/iga ov50 | GAMMAGARD LIQUID | IVIG/IMMUNE RELATED | J1569 | Yes | No | Yes |
immun glob g(igg)-hipp/maltose | CUTAQUIG | IVIG/IMMUNE RELATED | J1551 | Yes | No | No |
immun glob g(igg)-ifas/glycine | PANZYGA | IVIG/IMMUNE RELATED | J1576 | Yes | No | No |
immun globg(igg)/malt/iga ov50 | OCTAGAM | IVIG/IMMUNE RELATED | J1568 | Yes | No | No |
immun glob g(igg)/pro/iga 0-50 | HIZENTRA | IVIG/IMMUNE RELATED | J1559 | Yes | No | No |
immun glob g(igg)/pro/iga 0-50 | PRIVIGEN | IVIG/IMMUNE RELATED | J1459 | Yes | No | No |
immun glob g/sorb/gly/iga 0-50 | GAMMAPLEX | IVIG/IMMUNE RELATED | J1557 | Yes | No | No |
inclisiran sodium | LEQVIO | INJECTABLES - SPECIALTY OTHER | J1306 | Yes | No | Yes |
inebilizumab-cdon | UPLIZNA | MULTIPLE SCLEROSIS | J1823 | Yes | No | No |
infliximab | INFLIXIMAB | RA/PSORIASIS/CROHNS | J1745 | Yes | No | Yes |
infliximab | REMICADE | RA/PSORIASIS/CROHNS | J1745 | Yes | No | Yes |
infliximab-abda | RENFLEXIS | RA/PSORIASIS/CROHNS | Q5104 | Yes | No | Yes |
infliximab-axxq | AVSOLA | RA/PSORIASIS/CROHNS | Q5121 | Yes | No | No |
infliximab-dyyb | INFLECTRA | RA/PSORIASIS/CROHNS | Q5103 | Yes | No | No |
infliximab-dyyb | ZYMFENTRA | RA/PSORIASIS/CROHNS | J1748 | Yes | No | No |
ipilimumab | YERVOY | CANCER | J9228 | Yes | No | No |
ixabepilone | IXEMPRA | CANCER | J9207 | Yes | No | No |
lanreotide acetate | LANREOTIDE ACETATE | HORMONE RELATED | J1930 | Yes | No | No |
lanreotide acetate | LANREOTIDE ACETATE | INJECTABLES - SPECIALTY OTHER | J1932 | Yes | No | No |
lanreotide acetate | SOMATULINE DEPOT | HORMONE RELATED | J1930 | Yes | No | No |
laronidase | ALDURAZYME | HEREDITARY METABOLIC DISORDERS | J1931 | Yes | No | No |
lenacapavir sodium | SUNLENCA | INJECTABLES - SPECIALTY OTHER | J1961 | Yes | No | No |
leuprolide acetate | ELIGARD | HORMONE RELATED | J9217 | Yes | No | No |
leuprolide acetate | FENSOLVI | HORMONE RELATED | J1950 | Yes | No | No |
leuprolide acetate | FENSOLVI | HORMONE RELATED | J1951 | Yes | No | No |
leuprolide acetate | LEUPROLIDE DEPOT | INJECTABLES - SPECIALTY OTHER | J1954 | Yes | No | No |
leuprolide acetate | LUPRON DEPOT | HORMONE RELATED | J1950 | Yes | No | No |
leuprolide acetate | LUPRON DEPOT | HORMONE RELATED | J9217 | Yes | No | No |
leuprolide acetate | LUPRON DEPOT-PED | HORMONE RELATED | J1950 | Yes | No | No |
loncastuximab tesirine-lpyl | ZYNLONTA | CANCER | J9359 | Yes | No | No |
lumasiran sodium | OXLUMO | HEREDITARY METABOLIC DISORDERS | J0224 | Yes | No | No |
luspatercept-aamt | REBLOZYL | INJECTABLES - SPECIALTY OTHER | J0896 | Yes | No | No |
mepolizumab | NUCALA | ASTHMA/ALLERGY | J2182 | Yes | No | No |
methoxy peg-epoetin beta | MIRCERA | ANEMIA | J0888 | Yes | No | No |
mirikizumab-mrkz | OMVOH | RA/PSORIASIS/CROHNS | J2267 | Yes | No | No |
mirvetuximab soravtansine-gynx | ELAHERE | CANCER | J9063 | Yes | No | No |
mosunetuzumab-axgb | LUNSUMIO | CANCER | J9350 | No | No | No |
natalizumab | TYSABRI | MULTIPLE SCLEROSIS | J2323 | Yes | No | No |
nivolumab | OPDIVO | CANCER | J9299 | Yes | No | No |
nivolumab-hyaluronidase-nvhy | OPDIVO QVANTIG | CANCER | J9999 | Yes | Yes | No |
nivolumab-relatlimab-rmbw | OPDUALAG | CANCER | J9298 | Yes | No | No |
nogapendekin alfa inbakic-pmln | ANKTIVA | CANCER | J9028 | Yes | No | Yes |
nusinersen sodium/pf | SPINRAZA | GENETIC NEUROMUSCLAR DISORDERS | J2326 | Yes | No | No |
obinutuzumab | GAZYVA | CANCER | J9301 | Yes | No | No |
ocrelizumab | OCREVUS | MULTIPLE SCLEROSIS | J2350 | Yes | No | No |
ocrelizumab-hyaluronidase-ocsq | OCREVUS ZUNOVO | MULTIPLE SCLEROSIS | J2351 | Yes | No | No |
ocrelizumab-hyaluronidase-ocsq | OCREVUS ZUNOVO | MULTIPLE SCLEROSIS | J3590 | Yes | No | No |
octreotide acetate,mi-spheres | OCTREOTIDE ACETATE ER | HORMONE RELATED | J2353 | Yes | No | Yes |
octreotide acetate,mi-spheres | SANDOSTATIN LAR DEPOT | HORMONE RELATED | J2353 | Yes | No | Yes |
olipudase alfa-rpcp | XENPOZYME | HEREDITARY METABOLIC DISORDERS | J0218 | Yes | No | No |
omalizumab | XOLAIR | ASTHMA/ALLERGY | J2357 | Yes | No | No |
paclitaxel protein-bound | ABRAXANE | CANCER | J9264 | Yes | No | No |
paclitaxel protein-bound | PACLITAXEL PROTEIN-BOUND | CANCER | J9259 | Yes | No | No |
paclitaxel protein-bound | PACLITAXEL PROTEIN-BOUND | CANCER | J9264 | Yes | No | No |
palivizumab | SYNAGIS | INFECTIOUS DISEASE | 90378 | Yes | No | No |
panitumumab | VECTIBIX | CANCER | J9303 | Yes | No | No |
parathyroid hormone | NATPARA | INJECTABLES - SPECIALTY OTHER | J3590 | Yes | No | No |
pasireotide pamoate | SIGNIFOR LAR | INJECTABLES - SPECIALTY OTHER | J2502 | Yes | No | Yes |
patisiran sodium,lipid complex | ONPATTRO | GENETIC NEUROMUSCLAR DISORDERS | J0222 | Yes | No | No |
pegfilgrastim | NEULASTA | NEUTROPENIA | J2506 | Yes | No | No |
pegfilgrastim | NEULASTA ONPRO | NEUTROPENIA | J2506 | Yes | No | Yes |
pegfilgrastim-apgf | NYVEPRIA | NEUTROPENIA | Q5122 | Yes | No | No |
pegfilgrastim-bmez | ZIEXTENZO | NEUTROPENIA | Q5120 | Yes | No | Yes |
pegfilgrastim-cbqv | UDENYCA | NEUTROPENIA | Q5111 | Yes | No | No |
pegfilgrastim-cbqv | UDENYCA AUTOINJECTOR | NEUTROPENIA | Q5111 | Yes | No | No |
pegfilgrastim-cbqv | UDENYCA ONBODY | NEUTROPENIA | Q5111 | Yes | No | No |
pegfilgrastim-fpgk | STIMUFEND | NEUTROPENIA | Q5127 | Yes | No | Yes |
pegfilgrastim-jmdb | FULPHILA | NEUTROPENIA | Q5108 | Yes | No | Yes |
pegfilgrastim-pbbk | FYLNETRA | NEUTROPENIA | Q5130 | Yes | No | Yes |
pegloticase | KRYSTEXXA | AUTOIMMUNE/OTHER INFLAMMATORY | J2507 | Yes | No | No |
pegunigalsidase alfa-iwxj | ELFABRIO | HEREDITARY METABOLIC DISORDERS | J2508 | Yes | No | No |
pembrolizumab | KEYTRUDA | CANCER | J9271 | Yes | No | No |
pemetrexed | PEMETREXED | CANCER | J9305 | Yes | No | No |
pemetrexed disodium | ALIMTA | CANCER | J9305 | Yes | No | No |
pemetrexed disodium | PEMETREXED DISODIUM | CANCER | J9305 | Yes | No | No |
pertuzumab | PERJETA | CANCER | J9306 | Yes | No | No |
pertuzumab-trastuzumab-hy-zzxf | PHESGO | CANCER | J9316 | Yes | No | No |
plasminogen, human-tvmh | RYPLAZIM | OTHER BLOOD DISORDERS | J2998 | Yes | No | No |
pozelimab-bbfg | VEOPOZ | OTHER BLOOD DISORDERS | J9376 | Yes | No | No |
pralatrexate | FOLOTYN | CANCER | J9307 | Yes | No | No |
pralatrexate | PRALATREXATE | CANCER | J9307 | Yes | No | No |
protein c, human | CEPROTIN | OTHER BLOOD DISORDERS | J2724 | Yes | No | No |
ramucirumab | CYRAMZA | CANCER | J9308 | Yes | No | No |
ravulizumab-cwvz | ULTOMIRIS | OTHER BLOOD DISORDERS | J1303 | Yes | No | No |
reslizumab | CINQAIR | ASTHMA/ALLERGY | J2786 | Yes | No | Yes |
risankizumab-rzaa | SKYRIZI | INJECTABLES - SPECIALTY OTHER | J2327 | Yes | No | No |
rituximab | RITUXAN | CANCER | J9312 | Yes | No | Yes |
rituximab-abbs | TRUXIMA | CANCER | Q5115 | Yes | No | No |
rituximab-arrx | RIABNI | CANCER | Q5123 | Yes | No | No |
rituximab/hyaluronidase,human | RITUXAN HYCELA | CANCER | J9311 | Yes | No | Yes |
rituximab-pvvr | RUXIENCE | CANCER | Q5119 | Yes | No | No |
romiplostim | NPLATE | OTHER BLOOD DISORDERS | J2802 | Yes | No | No |
romosozumab-aqqg | EVENITY | BONE | J3111 | Yes | No | No |
romosozumab-aqqg | EVENITY (2 SYRINGES) | BONE | J3111 | Yes | No | No |
rozanolixizumab-noli | RYSTIGGO | INJECTABLES - SPECIALTY OTHER | J9333 | Yes | No | No |
sacituzumab govitecan-hziy | TRODELVY | CANCER | J9317 | Yes | No | No |
sebelipase alfa | KANUMA | HEREDITARY METABOLIC DISORDERS | J2840 | Yes | No | No |
secukinumab | COSENTYX | RA/PSORIASIS/CROHNS | J3247 | Yes | No | No |
siltuximab | SYLVANT | CANCER | J2860 | Yes | No | No |
sirolimus protein-bound | FYARRO | CANCER | J9331 | Yes | No | No |
spesolimab-sbzo | SPEVIGO | RA/PSORIASIS/CROHNS | J1747 | Yes | No | No |
sutimlimab-jome | ENJAYMO | OTHER BLOOD DISORDERS | J1302 | Yes | No | No |
taliglucerase alfa | ELELYSO | HEREDITARY METABOLIC DISORDERS | J3060 | Yes | No | No |
talquetamab-tgvs | TALVEY | CANCER | J3055 | Yes | No | No |
tarlatamab-dlle | IMDELLTRA | CANCER | J9026 | Yes | No | No |
tebentafusp-tebn | KIMMTRAK | CANCER | J9274 | Yes | No | No |
teclistamab-cqyv | TECVAYLI | CANCER | J9380 | No | No | No |
temsirolimus | TEMSIROLIMUS | CANCER | J9330 | Yes | No | No |
temsirolimus | TORISEL | CANCER | J9330 | Yes | No | No |
teplizumab-mzwv | TZIELD | INJECTABLES - SPECIALTY OTHER | J9381 | Yes | No | No |
teprotumumab-trbw | TEPEZZA | AUTOIMMUNE/OTHER INFLAMMATORY | J3241 | Yes | No | No |
testosterone undecanoate | AVEED | HORMONE RELATED | J3145 | Yes | No | No |
tezepelumab-ekko | TEZSPIRE | INJECTABLES - SPECIALTY OTHER | J2356 | Yes | No | No |
tildrakizumab-asmn | ILUMYA | RA/PSORIASIS/CROHNS | J3245 | Yes | No | No |
tislelizumab-jsgr | TEVIMBRA | CANCER | J9329 | Yes | No | No |
tisotumab vedotin-tftv | TIVDAK | CANCER | J9273 | Yes | No | No |
tocilizumab | ACTEMRA | RA/PSORIASIS/CROHNS | J3262 | Yes | No | No |
tocilizumab-aazg | TYENNE | RA/PSORIASIS/CROHNS | Q5135 | Yes | No | No |
tocilizumab-bavi | TOFIDENCE | RA/PSORIASIS/CROHNS | Q5133 | Yes | No | Yes |
tofersen | QALSODY | GENETIC NEUROMUSCLAR DISORDERS | J1304 | Yes | No | No |
toripalimab-tpzi | LOQTORZI | CANCER | J3263 | Yes | No | No |
trastuzumab | HERCEPTIN | CANCER | J9355 | Yes | No | Yes |
trastuzumab-anns | KANJINTI | CANCER | Q5117 | Yes | No | No |
trastuzumab-dkst | OGIVRI | CANCER | Q5114 | Yes | No | No |
trastuzumab-dttb | ONTRUZANT | CANCER | Q5112 | Yes | No | Yes |
trastuzumab-hyaluronidase-oysk | HERCEPTIN HYLECTA | CANCER | J9356 | Yes | No | Yes |
trastuzumab-pkrb | HERZUMA | CANCER | Q5113 | Yes | No | Yes |
trastuzumab-qyyp | TRAZIMERA | CANCER | Q5116 | Yes | No | No |
trastuzumab-strf | HERCESSI | CANCER | Q5146 | Yes | No | No |
tremelimumab-actl | IMJUDO | CANCER | J9347 | Yes | No | No |
treprostinil sodium | REMODULIN | PAH/VASODILATORS | J3285 | Yes | No | Yes |
treprostinil sodium | TREPROSTINIL | PAH/VASODILATORS | J3285 | Yes | No | No |
triptorelin pamoate | TRELSTAR | CANCER | J3315 | Yes | No | No |
ublituximab-xiiy | BRIUMVI | MULTIPLE SCLEROSIS | J2329 | Yes | No | No |
vedolizumab | ENTYVIO | RA/PSORIASIS/CROHNS | J3380 | Yes | No | No |
vedolizumab | ENTYVIO PEN | RA/PSORIASIS/CROHNS | J3590 | Yes | No | No |
velaglucerase alfa | VPRIV | HEREDITARY METABOLIC DISORDERS | J3385 | Yes | No | No |
velmanase alfa-tycv | LAMZEDE | HEREDITARY METABOLIC DISORDERS | J0217 | Yes | No | No |
vestronidase alfa-vjbk | MEPSEVII | HEREDITARY METABOLIC DISORDERS | J3397 | Yes | No | No |
viltolarsen | VILTEPSO | GENETIC NEUROMUSCLAR DISORDERS | J1427 | Yes | No | No |
von willebrand factor | VONVENDI | HEMOPHILIA | J7179 | Yes | No | No |
vutrisiran sodium | AMVUTTRA | INJECTABLES - SPECIALTY OTHER | J0225 | Yes | No | No |
zenocutuzumab-zbco | BIZENGRI | CANCER | J9999 | Yes | Yes | No |
zero row | LUNSUMIO | CANCER | J9350 | No | No | No |
zolbetuximab-clzb | VYLOY | CANCER | J9999 | Yes | No | No |